Your browser doesn't support javascript.
loading
Dynamics of IgM and IgG Antibody Response Profile against Linear B-Cell Epitopes from Exoerythrocytic (CelTOS and TRAP) and Erythrocytic (CyRPA) Phases of Plasmodium vivax: Follow-Up Study.
Rodolphi, Cinthia Magalhães; Soares, Isabela Ferreira; Matos, Ada da Silva; Rodrigues-da-Silva, Rodrigo Nunes; Ferreira, Marcelo Urbano; Pratt-Riccio, Lilian Rose; Totino, Paulo Renato Rivas; Scopel, Kézia Katiani Gorza; Lima-Junior, Josué da Costa.
Afiliação
  • Rodolphi CM; Research Centre of Parasitology, Department of Parasitology, Microbiology and Immunology and Post-Graduation Program in Biological Science, Federal University of Juiz de Fora, Juiz de Fora 36036-900, Brazil.
  • Soares IF; Laboratory of Immunoparasitology, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-900, Brazil.
  • Matos ADS; Laboratory of Immunoparasitology, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-900, Brazil.
  • Rodrigues-da-Silva RN; Laboratory of Hantaviruses and Rickettsioses, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-900, Brazil.
  • Ferreira MU; Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, Sao Paulo 05508-220, Brazil.
  • Pratt-Riccio LR; Laboratory for Malaria Research, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-900, Brazil.
  • Totino PRR; Center for Research, Diagnosis, and Training in Malaria of Fiocruz, Rio de Janeiro 21040-900, Brazil.
  • Scopel KKG; Laboratory for Malaria Research, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-900, Brazil.
  • Lima-Junior JDC; Center for Research, Diagnosis, and Training in Malaria of Fiocruz, Rio de Janeiro 21040-900, Brazil.
Antibodies (Basel) ; 13(3)2024 Aug 15.
Article em En | MEDLINE | ID: mdl-39189240
ABSTRACT
Malaria is a serious health problem worldwide affecting mainly children and socially vulnerable people. The biological particularities of P. vivax, such as the ability to generate dormant liver stages, the rapid maturation of gametocytes, and the emergence of drug resistance, have contributed to difficulties in disease control. In this context, developing an effective vaccine has been considered a fundamental tool for the efficient control and/or elimination of vivax malaria. Although recombinant proteins have been the main strategy used in designing vaccine prototypes, synthetic immunogenic peptides have emerged as a viable alternative for this purpose. Considering, therefore, that in the Brazilian endemic population, little is known about the profile of the humoral immune response directed to synthetic peptides that represent different P. vivax proteins, the present work aimed to map the epitope-specific antibodies' profiles to synthetic peptides representing the linear portions of the ookinete and sporozoite cell passage protein (CelTOS), thrombospondin-related adhesive protein (TRAP), and cysteine-rich protective antigen (CyRPA) proteins in the acute (AC) and convalescent phases (Conv30 and Conv180 after infection) of vivax malaria. The results showed that the studied subjects responded to all proteins for at least six months following infection. For IgM, a few individuals (3-21%) were positive during the acute phase of the disease; the highest frequencies were observed for IgG (28-57%). Regarding the subclasses, IgG2 and IgG3 stood out as the most prevalent for all peptides. During the follow-up, the stability of IgG was observed for all peptides. Only one significant positive correlation was observed between IgM and exposure time. We conclude that for all the peptides, the immunodominant epitopes are recognized in the exposed population, with similar frequency and magnitude. However, if the antibodies detected in this study are potential protectors, this needs to be investigated.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Antibodies (Basel) Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Antibodies (Basel) Ano de publicação: 2024 Tipo de documento: Article